Q4 drug pricing brings mostly mild changes, with a few big gainers, losers
What may be the last quarterly average sales price (ASP) update before a final rule changes the way Medicare reimburses providers for hundreds of drugs is out, with some big changes but a mostly level schedule/
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.